Axogen, Inc. Other Nonoperating Expense
Axogen, Inc. (AXGN) reported Other Nonoperating Expense of $278.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-02-25
- Axogen, Inc. other nonoperating expense for the quarter ending 2019-03-31 was $3.00K, a 200.00% increase year-over-year.
- Axogen, Inc. other nonoperating expense for the quarter ending 2018-12-31 was $12.40K, a 120.99% increase year-over-year.
- Axogen, Inc. other nonoperating expense for the quarter ending 2018-09-30 was $126.00, a 92.14% decline year-over-year.
- Axogen, Inc. other nonoperating expense for the quarter ending 2018-06-30 was $15.24K, a 8.59% increase year-over-year.
- Axogen, Inc. other nonoperating expense for fiscal 2021 was $278.00K, a 631.58% increase from fiscal 2020.
- Axogen, Inc. other nonoperating expense for fiscal 2020 was $38.00K, a 28.30% decline from fiscal 2019.
- Axogen, Inc. other nonoperating expense for fiscal 2019 was $53.00K, a 89.29% increase from fiscal 2018.
- Axogen, Inc. other nonoperating expense for fiscal 2018 was $28.00K, a 9.68% decline from fiscal 2017.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 3 month as first filed | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $278.00K 10-K · filed 2022-02-25 | ||||
| 2020-12-31 | $38.00K 10-K · filed 2022-02-25 | ||||
| 2019-12-31 | $53.00K 10-K · filed 2022-02-25 | ||||
| 2019-03-31 | $3.00K 10-Q · filed 2019-05-08 | $15.40K derived: sum of 2 quarters · filed 2021-03-01 | $15.53K derived: sum of 3 quarters · filed 2021-03-01 | $30.77K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $12.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $12.53K derived: sum of 2 quarters · filed 2021-03-01 | $27.77K derived: sum of 3 quarters · filed 2021-03-01 | $28.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $126.00 10-Q · filed 2018-10-29 | $15.36K derived: sum of 2 quarters · filed 2018-10-29 | $15.60K 10-Q · filed 2018-10-29 | $21.98K derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $15.24K 10-Q · filed 2018-08-01 | $15.47K 10-Q · filed 2018-08-01 | $21.85K derived: sum of 3 quarters · filed 2020-02-24 | $23.45K derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | $1.00K 10-Q · filed 2019-05-08 | $235.00 10-Q · filed 2018-04-30 | $6.61K derived: sum of 2 quarters · filed 2020-02-24 | $8.21K derived: sum of 3 quarters · filed 2020-02-24 | $22.25K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $5.61K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $7.21K derived: sum of 2 quarters · filed 2020-02-24 | $21.25K derived: sum of 3 quarters · filed 2020-02-24 | $31.00K 10-K · filed 2020-02-24 | |
| 2017-09-30 | $1.60K 10-Q · filed 2018-10-29 | $15.63K derived: sum of 2 quarters · filed 2018-10-29 | $25.39K 10-Q · filed 2018-10-29 | ||
| 2017-06-30 | $14.03K 10-Q · filed 2018-08-01 | $23.79K 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $9.75K 10-Q · filed 2018-04-30 | ||||
| 2016-12-31 | $20.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |